JEANNIE JHU: Open Payments
NPI 1831259241 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,953 in 82 payments from 17 companies in 2025. Trend: 2023 $3,286 · 2024 $4,238 · 2025 $2,953
Food & beverage: $2,953
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 14 | $606 |
| GENZYME CORPORATION | 10 | $352 |
| Galderma Laboratories, L.P. | 3 | $337 |
| Incyte Corporation | 8 | $261 |
| Janssen Biotech, Inc. | 5 | $248 |
| ABBVIE INC. | 5 | $231 |
| UCB, Inc. | 6 | $146 |
| Regeneron Healthcare Solutions, Inc. | 4 | $145 |
| LEO Pharma Inc. | 11 | $139 |
| PFIZER INC. | 4 | $104 |
Products named: Zoryve, DUPIXENT, OPZELURA, TREMFYA, NEMLUVIO, SKYRIZI, Bimzelx, ADBRY.
Industry payments across CA — which companies pay providers there.
